SRPK2 Antibodies

Santa Cruz Biotechnology provides a broad selection of SRPK2 monoclonal antibodies for investigating SRPK2 in cellular processes. SRPK2 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SRPK2, or Serine/Arginine Protein Kinase 2, plays an essential role in regulating pre-mRNA splicing and participates in various cellular signaling pathways. SRPK2 maintains proper gene expression through its kinase activity and influences cell proliferation and differentiation. Research has shown SRPK2's significance in cancer development and progression. SRPK2 has emerged as a potential therapeutic target in neurodegenerative disorders. Ongoing studies continue to reveal new functions of SRPK2 in cellular homeostasis and disease mechanisms. Understanding SRPK2's molecular interactions provides valuable insights into developing targeted therapies. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of SRPK2's role in health and disease.